Id Job: 316e324
With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
We are looking for an individual with a proven track record of generating and interpreting plate-based pharmacology data from a wide variety of assay technologies and lab-based environments. You will have experience in setting up, running and supporting plate-based in vitro assays; from assay design to development of primary screens, biochemical/whole-cell and high content assays. Through your Pharmaceutical or CRO experience, you will have a good understanding of the data elements of in vitro drug discovery, such as data analysis and ELN capture in platforms like Dotmatics.
You may be a lab based scientist looking to step away from the lab, but continue to utilise your bench skills and knowledge through interactions with Contract Research Organisations (CRO) and partner lines. You will join a team of enthusiastic and highly motivated biologists within the Discovery Enabling Team (DET), working across various BenevolentAI Projects on assay set-up and screen implementation, in order to generate robust and high quality data sets to enable confident project decision making. As an experienced drug discovery scientist, you will work directly with multiple BAI project teams across our entire portfolio, including in vitro Biology, Safety, DMPK, Chemistry and Informatics, to drive our AI-driven drug discovery pipeline.
This role can be based in either of our London or Cambridge locations.
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the ‘apply’ button and join us.
